GlaxoSmithKline (NYSE:GSK) is not giving up finding a role for enlarged prostate drug Avodart as a prostate cancer treatment. A study published today in The Lancet suggests that Avodart, also called ...
If you are pregnant, or planning to get pregnant, our medical advisers warn you to steer clear of the drug dutasteride (Avodart and generic) since it can cause birth defects, and the risks can ...
Drugmakers in South Korea are moving in to take market share from GlaxoSmithKline ($GSK), which saw its prostatic hyperplasia and hair loss medication treatment ...
GlaxoSmithKline ($GSK) has one less tool for propping up its top line. The company's prostate drug Avodart now faces a generic version from Teva Pharmaceutical ...
Local drugmakers have begun a competition to secure their portion of South Korea’s prostatic hyperplasia and hair loss medication market, as the last of GlaxoSmithKline’s Korean patents on Avodart ...
PHILADELPHIA A new study that will be published in the Journal of Urology shows that men with enlarged prostates who took a combination of two medications, Avodart and tamsulosin hydrochloride, the ...
WASHINGTON -- A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading. The British drugmaker's ...
(Boston) -- Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic ...
It was good news for GlaxoSmithKline yesterday after a long-term study clearly demonstrated the benefits of using a combination of Avodart and tamsulosin in the treatment of men with benign prostatic ...
Full results of a big study testing a drug for preventing prostate cancer show a higher risk of heart failure, a surprise finding that could dampen enthusiasm for expanding its use. On Monday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results